This application represents a renewal of the AIDS Malignancy Bank (AMB), now known as the AIDS and Cancer Specimen Bank (ACSB), program initially funded by the National Cancer Institute (NCI) in 1994. Since the initiation of this program, five participating institutions have successfully organized a national AIDS and Cancer Specimen Bank. The ACSB contains 43 categories of malignancy specimens and controls with specimen associated clinical information. The UCSF-ACSB specific aims for this proposal are: 1) to develop a cohesive West Coast based AIDS and Cancer Specimen Bank (ACSB) consortium centered at the University of California, San Francisco (UCSF); 2) to expand and enhance the UCSF-ACSB function; and 3) to actively participate in the national ACSB and fulfill NCI requirements for continued ACSB participation. In the first specific aim, USC and UCSD will be added to the original UCSF consortium. Dr. Parkash Gill at USC will oversee sample acquisition from a centralized base in Los Angeles. Dr. Brian Herndier, until recently the UCSF based ACSB pathologist will initiate a new ACSB site in San Diego. UCSF?s affiliated hospitals including SFGH, Laguna Honda, VAMC, and Mt. Zion will continue to anchor the San Francisco ACSB core. These San Francisco sites have more than 200,000 specimens banked and during the next five years will serve not only as a useful resource but as a coordinated network for obtaining new specimens as research questions in the scientific community evolve. In the second specific aim, the West Coast ACSB will work with existing specimen banks to merge data from their databases so as to increase access to relevant specimens already in existence. Specifically, the UCSF-AIDS Specimen Bank has made available 173,000 AIDS related specimens obtained since 1983 to the ACSB. Information on active contributors will serve as a network for obtaining new specimens. This interface between West Coast ACSB and a large existing specimen bank is a model for """"""""virtual"""""""" banking planned for future ACSB development through the ACSB Central Operations and Data Coordinating Center (CODCC) to be established next year. Finally, the West Coast ACSB has incorporated two major consortium sites in southern California that are responsive to the overall objectives of the ACSB made by this RFA. The coordinated interaction between this West Coast consortium with other funded ACSB sites will be assured by Dr. McGrath?s continued participation in the overall leadership of the national ACSB.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA066529-10
Application #
6656873
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (J2))
Program Officer
Bhatia, Kishor
Project Start
2002-09-16
Project End
2007-05-31
Budget Start
2003-06-13
Budget End
2004-05-31
Support Year
10
Fiscal Year
2003
Total Cost
$1,313,869
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Lee, Guinevere Q; Bangsberg, David R; Mo, Theresa et al. (2017) Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS 31:2345-2354
Lee, Guinevere Q; McCluskey, Suzanne; Boum 2nd, Yap et al. (2017) Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa? J Acquir Immune Defic Syndr 76:188-192
Lee, Guinevere Q; Lachowski, Chris; Cai, Eric et al. (2016) Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda. AIDS 30:1781-8
Matthews, Lynn T; Ribaudo, Heather B; Kaida, Angela et al. (2016) HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr 71:399-406
Chan, Brian T; Weiser, Sheri D; Boum, Yap et al. (2015) Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav 19:19-26
Kane, Eleanor; Skibola, Christine F; Bracci, Paige M et al. (2015) Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev 24:1061-70
Byakwaga, Helen; Hunt, Peter W; Laker-Oketta, Miriam et al. (2015) The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa. J Acquir Immune Defic Syndr 70:296-303
Chan, Brian T; Weiser, Sheri D; Boum, Yap et al. (2015) Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS 29:83-90
Nieves, Christina I; Kaida, Angela; Seage 3rd, George R et al. (2015) The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception 92:152-9
Lee, Guinevere Q; Bangsberg, David R; Muzoora, Conrad et al. (2014) Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda. AIDS Res Hum Retroviruses 30:896-906

Showing the most recent 10 out of 51 publications